AHA 2017 Scientific Sessions
End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.
Based on the pathophysiological and clinical characteristics of N-ERD, anti-IL 5 therapy may be effective in this patient subgroup.
ACR/ARHP 2016 Annual Meeting
The trial compares short- and long-term outcomes of Cimzia and Humira in RA